Certain Radiotherapy Systems and Treatment Planning Software, and Components Thereof; Institution of Investigation

Federal Register, Volume 80 Issue 210 (Friday, October 30, 2015)

Federal Register Volume 80, Number 210 (Friday, October 30, 2015)

Notices

Pages 66934-66935

From the Federal Register Online via the Government Publishing Office www.gpo.gov

FR Doc No: 2015-27668

=======================================================================

-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

Inv. No. 337-TA-968

Certain Radiotherapy Systems and Treatment Planning Software, and Components Thereof; Institution of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on September 25, 2015, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of Varian Medical Systems, Inc. of Palo Alto, California and Varian Medical Systems International AG of Switzerland. Supplements were filed on October 13, 2015. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain radiotherapy systems and treatment planning software, and components thereof by reason of infringement of certain claims of U.S. Patent No. 7,945,021 (``the '021 patent''); U.S. Patent No. 8,116,430 (``the '430 patent''); U.S. Patent No. 8,867,703 (``the '703 patent''); U.S. Patent No. 7,880,154 (``the '154 patent''); U.S. Patent No. 7,906,770 (``the '770 patent''); and U.S. Patent No. 8,696,538 (``the '538 patent''). The complaint further alleges that an industry in the United States exists as required by subsection (a)(2) of section 337.

The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

ADDRESSES: The complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Room 112, Washington, DC 20436, telephone (202) 205-2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission's TDD terminal on (202) 205-1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at (202) 205-

2000. General information concerning the Commission may also be obtained by accessing its internet server at http://www.usitc.gov. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at http://edis.usitc.gov.

FOR FURTHER INFORMATION CONTACT: The Office of Unfair Import Investigations, U.S. International Trade Commission, telephone (202) 205-2560.

Authority: The authority for institution of this investigation is contained in section 337 of the Tariff Act of 1930, as amended, and in section 210.10 of the Commission's Rules of Practice and Procedure, 19 CFR 210.10 (2015).

Scope of Investigation: Having considered the complaint, the U.S. International Trade Commission, on October 26, 2015, ordered that--

(1) Pursuant to subsection (b) of section 337 of the Tariff Act of 1930, as amended, an investigation be instituted to determine whether there is a violation of subsection (a)(1)(B) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain radiotherapy systems and treatment planning software, and components thereof by reason of infringement of one or more of claims 1, 2, 4-9, 11-16, 53-

56, and 58-62 of the '021 patent; claims 1-4, 6-10, 12, 18, and 19 of the '430 patent; claims 1-10, 12-15, and 17-21 of the '703 patent; claims 19-28 and 33-36 of the '154 patent; claims 61-63, 65, and 67-70 of the '770 patent; and claims 23, 25, 26, 39-42, 45, and 50 of the '538 patent, and whether an industry in the United States exists as required by subsection (a)(2) of section 337;

(2) Pursuant to Commission Rule 210.50(b)(1), 19 CFR 210.50(b)(1), the presiding administrative law judge shall take evidence or other information and hear arguments from the parties and other interested persons with respect to the public interest in this investigation, as appropriate, and provide the Commission with findings of fact and a recommended determination on this issue, which shall be limited to the statutory public interest factors set forth in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);

(3) For the purpose of the investigation so instituted, the following are hereby named as parties upon which this notice of investigation shall be served:

(a) The complainants are:

Varian Medical Systems, Inc., 3100 Hansen Way, Palo Alto, CA 94304.

Varian Medical Systems International AG, Hinterbergstrasse 14, 6330 Cham, ZG, Switzerland.

(b) The respondents are the following entities alleged to be in violation of section 337, and are the parties upon which the complaint is to be served:

Elekta AB, Kungstensgatan 18, SE-103 93 Stockholm, Sweden.

Elekta Ltd., Linac House, Fleming Way, RH10 9RR Crawley, United Kingdom.

Elekta GmbH, Borsteler Chaussee 49, 22453 Hamburg, Germany.

Elekta Inc., 400 Perimeter Center Terrace, Suite 50, Atlanta, GA 30346.

IMPAC Medical Systems, Inc., 100 Mathilda Place, 5th Floor, Sunnyvale, CA 94086 .

Elekta Instrument (Shanghai) Limited, Room 3202 & 3203, Pangu Plaza, Office Building, Block A, No. 27 Fourth Ring Mid Road, Chaoyang District, 100101 Shanghai, China.

Elekta Beijing Medical Systems Co. Ltd., No. 21, Chuang Xin Road, Science, & Technology Park, Chang Ping, Beijing, 102200, China.

(c) The Office of Unfair Import Investigations, U.S. International Trade Commission, 500 E Street SW., Suite 401, Washington, DC 20436; and

(4) For the investigation so instituted, the Chief Administrative Law Judge, U.S. International Trade Commission, shall designate the presiding Administrative Law Judge.

Responses to the complaint and the notice of investigation must be submitted by the named respondents in accordance with section 210.13 of the Commission's Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the complaint and the notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown.

Failure of a respondent to file a timely response to each allegation in the complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the

Page 66935

allegations of the complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of an exclusion order or a cease and desist order or both directed against the respondent.

By order of the Commission.

Issued: October 26, 2015.

William R. Bishop,

Supervisory Hearings and Information Officer.

FR Doc. 2015-27668 Filed 10-29-15; 8:45 am

BILLING CODE 7020-02-P